Table of Contents

2019-2024 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption 2014-2024
  • 2.1.2 Nuclear Medicine/Radiopharmaceuticals Consumption CAGR by Region
• 2.2 Nuclear Medicine/Radiopharmaceuticals Segment by Type
  • 2.2.1 Diagnostic
  • 2.2.2 Therapeutic
• 2.3 Nuclear Medicine/Radiopharmaceuticals Consumption by Type
  • 2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Type (2014-2019)
• 2.4 Nuclear Medicine/Radiopharmaceuticals Segment by Application
  • 2.4.1 Oncology
  • 2.4.2 Thyroid
  • 2.4.3 Cardiology
• 2.5 Nuclear Medicine/Radiopharmaceuticals Consumption by Application
  • 2.5.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Nuclear Medicine/Radiopharmaceuticals Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Application (2014-2019)

3 Global Nuclear Medicine/Radiopharmaceuticals by Players

• 3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Players
  • 3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Players (2017-2019)
  • 3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Players (2017-2019)
• 3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Players
  • 3.2.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Players (2017-2019)
  • 3.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
• 3.3 Global Nuclear Medicine/Radiopharmaceuticals Sale Price by Players
• 3.4 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Nuclear Medicine/Radiopharmaceuticals Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Nuclear Medicine/Radiopharmaceuticals by Regions

• 4.1 Nuclear Medicine/Radiopharmaceuticals by Regions
  • 4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Regions
  • 4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Value by Regions
• 4.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption Growth
• 4.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption Growth
• 4.4 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Growth
• 4.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption Growth

5 Americas

• 5.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
  • 5.1.1 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 5.1.2 Americas Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
• 5.2 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Type
• 5.3 Americas Nuclear Medicine/Radiopharmaceuticals Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Countries
  • 6.1.1 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 6.1.2 APAC Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
• 6.2 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Type
• 6.3 APAC Nuclear Medicine/Radiopharmaceuticals Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries
  • 7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
• 7.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Type
• 7.3 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals by Countries
  • 8.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Value by Countries (2014-2019)
• 8.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Type
• 8.3 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Nuclear Medicine/Radiopharmaceuticals Distributors
• 10.3 Nuclear Medicine/Radiopharmaceuticals Customer

11 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast

• 11.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast (2019-2024)
• 11.2 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions
  • 11.2.1 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Regions (2019-2024)
  • 11.2.2 Global Nuclear Medicine/Radiopharmaceuticals Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Type
• 11.8 Global Nuclear Medicine/Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

• 12.1 China Isotope & Radiation
  • 12.1.1 Company Details
  • 12.1.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 China Isotope & Radiation News
• 12.2 Dongcheng
  • 12.2.1 Company Details
  • 12.2.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Dongcheng News
• 12.3 Jaco
  • 12.3.1 Company Details
  • 12.3.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Jaco News
• 12.4 Ciaeriar
  • 12.4.1 Company Details
  • 12.4.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Ciaeriar News
• 12.5 Advanced Molecular-imaging Solution
  • 12.5.1 Company Details
  • 12.5.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Advanced Molecular-imaging Solution News
• 12.6 Shanghai Atom Kexing
  • 12.6.1 Company Details
  • 12.6.2 Nuclear Medicine/Radiopharmaceuticals Product Offered
  • 12.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Shanghai Atom Kexing News

...

13 Research Findings and Conclusion

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.

According to this study, over the next five years the Nuclear Medicine/Radiopharmaceuticals market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nuclear Medicine/Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine/Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study considers the Nuclear Medicine/Radiopharmaceuticals value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diagnostic
Therapeutic
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Thyroid
Cardiology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Nuclear Medicine/Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nuclear Medicine/Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Nuclear Medicine/Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine/Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nuclear Medicine/Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.